Corcept Therapeutics Inc (CORT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$75.00

Buy

$85.30

arrow-up$2.22 (+2.72%)

Prices updated at 19 Dec 2025, 23:28 EST

Prices minimum 15 mins delay

Prices in USD

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

NASDAQ

1.31%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	482m	675m
	476m	664m
	107m	137m
	22.24	20.29
	106m	141m
	110m	138m
Sales, General and administrative	184m	280m
Interest expenses	-	-
Provision for income taxes	18m	20m
Operating expenses	369m	527m
Income before taxes	125m	161m
Net income available to common shareholders	105m	140m
	1.02	1.35
Net interest income	17m	25m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.94	1.23
Free cash flow per share	1.3644	1.2803
Book value/share	4.4648	6.0776
Debt equity ratio	-	0.008986

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	459m	472m
Current liabilities	105m	141m
Total capital	507m	680m
Total debt	151,000	7m
Total equity	507m	680m
Total non current liabilities	-	-
Loans	-	-
Total assets	622m	841m
Total liabilities	-	-
Cash and cash equivalents	136m	128m
Common stock	103m	105m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	66m	136m
Cash dividends paid	-	-
	127m	196m
Investments (gains) losses	91m	-178m
	136m	128m
Net income	-	-
	127m	198m
	-139,000	-2m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.